Samantha Dreher
Family Medicine · Westminster, CONPI 1790084093
Payments from drug & device makers
Across 104 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$305
- AbbVie$286
- Lilly USA, LLC$213
- GSK$177
- Novo Nordisk$153
- Amgen$146
- plus $805 from 19 others
What the payments were for
- Food & beverage$2,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $305 |
| AbbVie | 14 | $286 |
| Lilly USA, LLC | 13 | $213 |
| GSK | 10 | $177 |
| Novo Nordisk | 8 | $153 |
| Amgen | 8 | $146 |
| AstraZeneca | 7 | $123 |
| Bayer | 4 | $79 |
| Gilead | 3 | $78 |
| Myriad Women's Health, Inc. | 1 | $74 |
| Exact Sciences | 3 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $43 |
| Novartis | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Tactile Systems Technology Inc | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Lucid Diagnostics Inc. | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| VBI Vaccine (delaware) Inc. | 1 | $22 |
| Merck | 1 | $21 |
| Pfizer | 1 | $19 |
| Cranial Technologies, Inc | 1 | $15 |
| Viiv Healthcare Company | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
How this compares
$2,086 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $26,250 |
| MounjaroTirzepatide | 11 | $12,489 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,362 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $1,772 |
| Omeprazole | 45 | $1,327 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $1,322 |
| Rosuvastatin Calcium | 106 | $1,181 |
| Levothyroxine Sodium | 91 | $976 |
| Gabapentin | 26 | $954 |
| Potassium Chloride | 26 | $779 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $714 |
| Losartan Potassium | 67 | $659 |
| Celecoxib | 26 | $640 |
| Oxycodone Hcl | 17 | $637 |
| Lisinopril | 86 | $563 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $153 | $26,25020 claims |
| Lilly USA, LLCMounjaro | $213 | $12,48911 claims |
| GSKBreo Ellipta | $177 | $4,36211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Westminster
- Erik KramerWestminster$104K
- Gregory MaederWestminster$95K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.